Liu, Q. (2020). World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer. KeAi Communications Co., Ltd.
Chicago Style (17th ed.) CitationLiu, Qian. World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer. KeAi Communications Co., Ltd, 2020.
MLA (9th ed.) CitationLiu, Qian. World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer. KeAi Communications Co., Ltd, 2020.
Warning: These citations may not always be 100% accurate.